COMPOSITION PHARMACEUTIQUE STABLE POUR LE TRAITEMENT DE L'OSTÉOPOROSE
- 专利权人:
- Landsteiner Scientific S.A. de C.V.
- 发明人:
- 申请号:
- EP13859631.7
- 公开号:
- EP2926817A1
- 申请日:
- 2013.10.30
- 申请国别(地区):
- EP
- 年份:
- 2015
- 代理人:
- 摘要:
- This invention provides pharmaceutical compositions which increase the bioavailability of risedronate sodium and provides vitamin D3 with greater stability; these compositions are useful in the inhibition of bone resorption.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITION PHARMACEUTIQUE STABLE POUR LE TRAITEMENT DE L'OSTÉOPOROSE
- Combined use of 25-hydroxyvitamin d3 and vitamin d3 to improve bone mineral density and to treat osteoporosis
- Combined use of 25-hydroxy-vitamin D3 and vitamin D3 for improving bone mineral density and for treating osteoporosis
- COMBINED USE OF 25-HYDROXY-VITAMIN D3 AND VITAMIN D3 FOR IMPROVING BONE MINERAL DENSITY AND FOR TREATING OSTEOPOROSIS